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Introduction / objectives
Serotype replacement is a major concern following the
introduction of polysaccharide-conjugated vaccine
against S. pneumoniae and requires a close monitoring
in the population. Antibody-based serotyping methods
are expensive, semi quantitative, cross-reactions are
common and a significant number of isolates cannot be
typed. Multiplex PCR-based assays have been developed
but quantification of PCR products remains problematic.
To address these issues a novel PCR-based automated
microarray assay was developed and tested on clinical
samples.
Methods
Autolysin, pneumolysin and eight other genes located in
the capsular operon were first amplified using multiplex
PCR. This step was followed by a tagged primer exten-
sion step targeting serotype-specific polymorphisms.
The tagged primers were then assigned to a specific
spot on a microarray, and processed and scanned in an
ISO-certified automated molecular diagnostic system,
using a confocal laser microscope. Results from the
assay were exported to the analysis software/expert sys-
tem that transformed genetic typing data into capsular
serotype identification.
Results
Using this new technology, 51 serotypes of S. pneumo-
niae can be precisely and uniquely identified, including
the 13 types present in the new conjugate vaccine. The
remaining 39 are assigned to a serogroup. Blood, CSF
and nasopharyngeal samples from children with S. pneu-
moniae infection or carriage were tested and serotype
was confirmed by sequence analysis. 26 different
serotypes were detected and concordance between both
methods was greater than 96%.
Conclusion
This automated microarray assay is robust and could
identify precise serotypes of S. pneumoniae directly from
clinical samples. It is easy to handle and will be most
useful in clinical settings and for the evaluation of sero-
type prevalence changes.
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